Overview

Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients

Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the safety and efficacy of treatment with hypothyroxinemia adjunct to conventional therapies in GBM patients.
Phase:
Phase 2
Details
Lead Sponsor:
Musli Thyropeutics Ltd.
Collaborator:
Tel-Aviv Sourasky Medical Center
Treatments:
Methimazole